美国NDC目录

概述

本数据库包含了美国在售药品名称、活性成分、规格、剂型、给药途径、包装等相关信息，收录信息共计十五万余条。

数据结构及样例

{
  "药品名称":"ARBLI",
  "药品名称后缀":"",
  "通用名称":"losartan potassium",
  "公司名称":"Scienture LLC",
  "活性成分":"LOSARTAN POTASSIUM",
  "活性成分（中）":"氯沙坦钾",
  "规格":"10 mg/mL", 
  "给药途径":"口服",
  "剂型":"混悬剂",
  "产品NDC":"83245-053",
  "申请号":"218772",
  "上市日期":"2025-03-19",
  "停止销售日期":"",
  "NDC上市认证截止日期":"20261231",
  "申请类型":"新药申请",
  "批准日期":"2025-03-13",
  "NDC已排除标识":"N",
  "产品类型":"处方药",
  "辅料":"HYPROMELLOSES ;METHYLPARABEN ;PROPYLPARABEN ;POLYETHYLENE GLYCOL 400 ;POVIDONE ;PROPYLENE GLYCOL ;WATER ;DIMETHICONE ;SUCRALOSE ;XANTHAN GUM ;SODIUM PHOSPHATE, DIBASIC ;SODIUM PHOSPHATE, MONOBASIC ;SILICON DIOXIDE", 
  "黑框警告":"WARNING: FETAL TOXICITY When pregnancy is detected, discontinue Arbli as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions (5.1)].",
  "atc编码":"C09CA01",
  "说明书":"文件链接",
  "官网":"https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm",
  "DEA药物监管分类":"",
}